Publication | Closed Access

Impact of polymorphisms of the major histocompatibility complex class II, interleukin‐10, tumor necrosis factor‐α and cytotoxic T‐lymphocyte antigen‐4 genes on inhibitor development in severe hemophilia A

HistocompatibilityImmunogeneticsTumor Necrosis Factor‐αImmune Cell DevelopmentImmunodeficienciesHla ImmunogeneticsImmune RegulationImmunologyPathologyHematologyImmune SurveillanceInhibitor DevelopmentMedicineImmune SystemSevere Hemophilia AImmune-related Gene Polymorphism